When was AIMA Laboratories founded?

AIMA Laboratories was founded in 2021.

Where is AIMA Laboratories located?

AIMA Laboratories is headquartered in Hamilton, Canada. It is registered at 340 Front Road, St. Williams.

How many employees does AIMA Laboratories have?

As of May 31, 2026, the latest employee count at AIMA Laboratories is 8.

Where does AIMA Laboratories rank among its competitors?

AIMA Laboratories ranks 50th amongst 95 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Hera Biotech, which secured $250K in Sep, 2025.

Who are the top competitors of AIMA Laboratories?

AIMA Laboratories' top competitors include Fulgent Genetics, Invitae and Myriad Genetics. Among them, Hera Biotech secured the most recent funding round in September, 2025.

AIMA Laboratories - 2026 Company Profile, Team, Funding & Competitors

AIMA Laboratories is a funded company based in Hamilton (Canada), founded in 2021 by Jocelyn Wessels. It operates as a Developer of at-home blood test for gynecological health. The company has 95 active competitors, including 27 funded and 12 that have exited. Its top competitors include companies like Fulgent Genetics, Invitae and Myriad Genetics.

Company Details

Developer of at-home blood test for gynecological health. The company offers a blood test that identifies specific microRNA biomarkers that are differentially expressed in women with endometriosis compared to women without for the diagnosis and treatment of endometriosis, detecting and removing endometrial lesions.

Website: www.aimalaboratories.com/
Social
Registered Address: 340 Front Road, St. Williams

Key Metrics

Founded Year

2021

Location

Hamilton, Canada

Stage

Funding Raised

Investors

SOSV

Ranked

50^th among 95 active competitors

Employee Count

8 as on May 31, 2026

Similar Companies

Mimark & 17 more

View AIMA Laboratories' full profile

AIMA Laboratories is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Aima Laboratories Inc. CIN: 13494829 , Canada, Active	Nov 08, 2021	-	-	-

AIMA Laboratories is a funded company. AIMA Laboratories has 1 institutional investor.

View details of AIMA Laboratories's funding rounds and investors

The founders of AIMA Laboratories is Jocelyn Wessels.

Here are the details of AIMA Laboratories' key team members:

Jocelyn Wessels: Co-Founder of AIMA Laboratories.

View details of AIMA Laboratories's Founder profiles and Board Members

AIMA Laboratories' employee count trend

AIMA Laboratories has 8 employees as of May 26. Here is AIMA Laboratories's employee count trend over the years:

Employee count trend for AIMA Laboratories

Uncover AIMA Laboratories' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AIMA Laboratories include Fulgent Genetics, Invitae and Myriad Genetics. Here is the list of Top 10 competitors of AIMA Laboratories, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Fulgent Genetics 2011, Temple City (United States), Acquired	Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer	$34.8M	-	70/100
2nd	Invitae 2010, San Francisco (United States), Public	Provider of home-based genetic test for individuals	$190M	Perceptive Advisors, Rock Springs Capital ... & 22 others	64/100
3rd	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, TriplePoint Capital & 6 others	66/100
4th	Celmatix 2009, New York City (United States), Series C	Pioneering ovarian health therapeutics for women's unique biological needs	$24.9M	Topspin Consumer Partners, Partnership for New York City ... & 4 others	56/100
5th	Mimark 2021, Barcelona (Spain), Seed	Developer of diagnostic tools that utilize gynecological fluids to identify diseases	$7.49M	Namarel Ventures investor, Inveready & 10 others	54/100
6th	Genome Medical 2016, Monterey (United States), Series D	Provider of clinical and DTC genomic testing services	$173M	Samsung Catalyst Fund, Canaan & 21 others	54/100
7th	Hera Biotech 2020, San Antonio (United States), Seed	Developer of diagnostic test kit for endometriosis	$4.15M	Birmingham Angels, Coyote Ventures & 6 others	51/100
8th	AnchorDx 2015, Guangzhou (China), Series C	Developer of high throughput gene sequencing platform for clinical application	$73M	Orbimed, Frontline BioVentures & 5 others	48/100
9th	Blueprint Genetics 2012, Espoo (Finland), Acquired	Provider of genetic diagnostics and clinical interpretation for hereditary diseases	$26.2M	Inventure, MTIP & 4 others	48/100
10th	Recombine 2011, New York City (United States), Acquired	Genetic testing services	$12.1M	FirstMark, Vast Ventures & 3 others	48/100
50th	AIMA Laboratories 2021, Hamilton (Canada), Funding Raised	Developer of at-home blood test for gynecological health	-	SOSV	25/100